explore -WSS

explore

author：knowledge 2025-09-29 09:49:24 - browse：219

When is negative data positive enough? Who gets credit for scientific breakthroughs? And wasn’t biotech supposed to bounce back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain the story of Svetlana Mojsov, a chemist who played a vital role in the discovery of GLP-1 who has spent decades fighting for proper recognition. We also discuss the latest news in the life sciences, including the FDA hearing on a BrainStorm Cell Therapeutics’ polarizing ALS treatment, the end of the road for a once-vaunted drug developer, and the sorry state of biotech stocks.

For more on what we cover, here’s the Mojsov story; here’s the latest on BrainStorm; here’s the news on Intercept Pharmaceuticals; here’s more on the biotech market; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Alkermes shareholders re
Next article： Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

explore

WSS

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Be careful with at

A public health expert passes on football's full body collisions for youths

Be careful with at

Hospitals are dialing back on venture capital investing

Illinois Supreme Court finds assault weapons ban constitutional

explore

explore

focus

Virginia high school admissions case could be legal follow

Indictment alleges Trump's ex

Moonlake's readout produced a cash windfall. Risks remain

Patients, digital health players weigh in on FTC's data privacy plan

The high cost of giving birth even with insurance

Megan Rapinoe shares emotional post following US Women's World Cup exit

Psychedelics group wrestles with new pharma identity

After Optum profits sink, UnitedHealth makes changes

FDA approval of Sarepta Duchenne genetic therapy gives me hope

How to fix the rural physician shortage in the U.S.

explore

Xenotransplantation trials will require adjusting expectations, experts say

What to know about the judge who will handle the Trump case

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Treatments for cramps don't cut it. Why aren't there better options?

Reanimated hearts work just as well for transplants, study finds

Biden administration begins canceling student loan debt for 804,000 borrowers

knowledge

explore

hotspot

Wikipedia